IP Library › Assignment 013933/0496
Patent Assignment
Reel/Frame 013933/0496

Assignment of Assignor's Interest

Recorded: 2003-04-14 Pages: 41
Assignors
Assignee
ALLERGAN, INC.
25254 DUPONT DRIVE, IRVINE, CALIFORNIA, 92612
Covered Properties (374)
Bottle Cap
Patent: 279,357 →
Application: 06/496,753 →
Treatment of Cutaneous Hyperproliferative Dermatoses with Manoalide
Patent: 4,786,651 →
Application: 06/825,309 →
Method of Forming an Intraocular Lens
Patent: 4,702,865 →
Application: 06/876,178 →
2H-Pyran-2,6-(3H)-Dione Derivatives with Anti-Allergic Activity
Patent: 4,725,620 →
Application: 06/905,822 →
Ethynylphenyl-Containing Retinoic Acid Derivatives
Patent: 4,739,098 →
Application: 06/910,096 →
Acetylenes Disubstituted with a Phenyl Group and a Heterobicyclic Group Having Retinoid-Like Activity
Patent: 4,810,804 →
Application: 07/031,476 →
Ethynylheteroaromatic-Acids Having Retinoic Acid-Like Activity
Patent: 4,923,884 →
Application: 07/180,649 →
Thiochroman Esters of Phenols and Terephthallates Having Retinoid-Like Activity
Patent: 4,895,868 →
Application: 07/212,855 →
Process for Preparing 5-Substituted-3-Furaldehydes
Patent: 4,935,530 →
Application: 07/259,225 →
Ethynylheteroaromatic-Acids Having Retinoic Acid-Like Activity
Patent: 4,927,947 →
Application: 07/303,864 →
Biologically Stabilized Compositions Comprising Collagen as the Minor Component with Ethylenically Unsaturated Compounds Used as Contact Lenses
Patent: 33,997 →
Application: 07/323,361 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,089,509 →
Application: 07/326,191 →
Thiochroman Esters of Phenols and Terephthallates Having Retinoid-Like Activity
Patent: 5,015,658 →
Application: 07/366,831 →
Phenylethenyl Compounds Having Retinoid-Like Activity
Patent: 4,992,468 →
Application: 07/385,626 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2- Substituted Chromanyl, Thiochromanyl or 1,2,3,4-Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,045,551 →
Application: 07/409,476 →
Compounds Having a Disubstituted Acetylene Moiety and Retinoic Acid- Like Biological Activity
Patent: 5,023,341 →
Application: 07/409,477 →
Acetylenes Disubstituted with a Phenyl Group and a 2- Substituted Chromanyl or Thiochromanyl Group Having Retinoid-Like Activity
Patent: 4,980,369 →
Application: 07/409,488 →
Method for Reducing or Maintaining Intraocular Pressure
Patent: 5,034,406 →
Application: 07/412,528 →
(2-Imidazolin-2-Ylamino) Tetrahydroquinoxalines and Methods for Using Same
Patent: 5,077,292 →
Application: 07/420,817 →
Anti-Inflammatory Furanones
Patent: 5,089,485 →
Application: 07/426,243 →
Anti-Inflammatory Furanones
Patent: 4,957,917 →
Application: 07/427,201 →
Anti-Inflammatory 2-Furanones
Patent: 5,045,564 →
Application: 07/427,202 →
Anti-Inflammatory 5-Hydroxy-2-Furanones
Patent: 5,059,611 →
Application: 07/427,268 →
Method for Using (2-Imidazolin-2-Ylamino) Quinoxalines to Reduce or Maintain Intraocular Pressure
Patent: 5,021,416 →
Application: 07/429,835 →
Novel Pharmaceutical Epinephrine-Pilocarpine Derivatives Compounds
Patent: 5,055,467 →
Application: 07/434,914 →
N-Substituted Derivatives of 3R,4R-Ethyl-((1-Methyl-1H-Imidazol-5-Yl) Methyl)-2-Pyrrolidinone
Patent: 5,264,449 →
Application: 07/434,929 →
Chroman Esters of Phenols and Benzoic Acids Having Retinoid-Like Activity
Patent: 5,006,550 →
Application: 07/458,883 →
Acetylenes Disubstituted with a Pyridinyl Group and a Substituted Phenyl Group Having Retinoid Like Activity
Patent: 5,013,744 →
Application: 07/458,963 →
Ophthalmic Compositions and Methods for Preserving and Using Same
Patent: 5,171,526 →
Application: 07/461,161 →
Non Oxidative Ophthalmic Compositions and Methods for Preserving and Using Same
Patent: 5,145,643 →
Application: 07/461,181 →
Methods to Disinfect Contact Lenses
Patent: 5,279,673 →
Application: 07/461,405 →
Methods and Materials for Use in Corneal Wound Healing
Patent: 4,981,841 →
Application: 07/467,115 →
Alkyl, Alkoxy and Thioalkoxy Substituted Diphenyl Acetylenes Having Retinoid Like Activity
Patent: 5,202,471 →
Application: 07/475,690 →
Methods for Producing Amino-2-Imidazoline Derivatives
Patent: 5,130,441 →
Application: 07/475,842 →
Method for Reducing or Maintaining Intraocular Pressure in the Mammalian Eye by Administering Pharmaceutical Compositions Containing 2-(2-Alkylphenylamino)-Oxazolines, 2-(2-Alkylphenyl-Amino) -Thiazolines and 2-(2-Alkylphenylamino)-Imidazolines
Patent: 5,151,440 →
Application: 07/486,381 →
2-(Hydroxy-2-Alkylphenylamino)-Oxazolines and Thiazolines as Anti-Glaucoma and Vasoconstrictive Agents
Patent: 5,066,664 →
Application: 07/486,382 →
Use of Prostaglandin F3 Alpha as an Ocular Hypotensive Agent
Patent: 5,011,856 →
Application: 07/491,546 →
Intraocular Pressure Reducing Prostaglandin-Like 7-Oxabicyclo Derivates
Patent: 5,093,329 →
Application: 07/492,620 →
Ethynylheteroaromatic-Acids Having Retinoic Acid-Like Activity
Patent: 4,980,484 →
Application: 07/493,049 →
4-(1-Hydroxy-2-Substituted Amino)Ethyl-5-Hydroxy-2(5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,081,147 →
Application: 07/493,895 →
4-(1-Hydroxy-2-N-Substituted Sulfonamido) Ethyl-5-Hydroxy-2(5H)- Furanones and 4-(N-Substituted Sulfonamido)-2-Ethenyl-5-Hydroxy- 2(5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,081,261 →
Application: 07/498,337 →
4-Ethyl and 4-Ethenyl-5-Hydroxy-2(5H)-Furanones Substituted on Alpha Carbon of the Ethyl or Ethenyl Side Chain with a Long Chain Alkyl Group and on the Beta Carbon with a Polar Group, as Anti-Inflammatory Agents
Patent: 5,013,850 →
Application: 07/502,208 →
2(5H)-Furanones Substituted in the 3 Position, as CA2+ Channel Antagonists and Anti-Inflammatory Agents
Patent: 5,043,457 →
Application: 07/510,367 →
4-(Oxygen, Sulfur or Nitrogen Substituted)-Methyl 5-Hydroxy-2(5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,037,811 →
Application: 07/510,368 →
Pgf 1-Alcohols and Their Use as Ocular Hypotensives
Patent: 5,238,961 →
Application: 07/538,204 →
Reversible Gelation Compositions and Methods of Use
Patent: 5,252,318 →
Application: 07/539,061 →
Tetralin Esters of Phenols or Benzoic Acids Having Retinoid Like Activity
Patent: 5,130,335 →
Application: 07/558,737 →
(2-Imidazolin-2-Ylamino) Quinoxaline Derivatives and Methods for Using Same
Patent: 5,112,822 →
Application: 07/560,776 →
6- or 7- (2-Imino-2-Imidazolidine)-1,4-Benzoxazines as Alpha Adrenergic Agents
Patent: 5,091,528 →
Application: 07/582,034 →
Intraocular Pressure Reducing 9,15-Diacyl Prostaglandins
Patent: 5,028,624 →
Application: 07/584,370 →
Intraocular Pressure Reducing 9,11-Diacyl Prostaglandins
Patent: 5,034,413 →
Application: 07/585,284 →
Nonaqueous Flurinated Drug Delivery Vehicle Suspensions
Patent: 5,173,298 →
Application: 07/588,697 →
Intraocular Pressure Reducing 11-Acyl Prostaglandins
Patent: 5,446,041 →
Application: 07/596,430 →
Ethynyl-Chroman Compounds
Patent: 5,053,523 →
Application: 07/610,491 →
2-Decarboxyl-2-Aminoalkyl-Prostaglandins as Ocular Hypotensives
Patent: 5,270,049 →
Application: 07/611,029 →
2-Decarboxyl-2-Alkoxyalkyl Prostaglandins as Ocular Hypotensives
Patent: 5,139,491 →
Application: 07/623,234 →
Combination of Selective Alpha-Adrenergic Agonists and Na+/H+ Exchange Inhibitors Useful in Lowering Intraocular Pressure
Patent: 5,215,991 →
Application: 07/633,103 →
Stable Suspension Formulations for Controlled Delivery of Pharmaceutical Compounds
Patent: 5,275,820 →
Application: 07/634,500 →
Methods of Using Phenylethenyl Compounds Having Retinoid-Like Activity
Patent: 5,068,252 →
Application: 07/653,540 →
A Dispenser for Dispensing Sterile Solutions
Patent: 5,238,153 →
Application: 07/656,867 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Substituted Phenyl Group Having Retinoid Like Activity
Patent: 5,175,185 →
Application: 07/669,696 →
7-Chromanyl Esters of Phenols and Benzoic Acids Having Retinoid-Like Activity
Patent: 5,134,159 →
Application: 07/676,152 →
Use of Prostaglandin F3ALPHA as an Ocular Hypotensive Agent
Patent: 5,194,449 →
Application: 07/684,709 →
Intermediates and Processes for Preparing 4-Substituted 2-5(H)- Furanones as Anti-Inflammatory Agents
Patent: 5,082,954 →
Application: 07/690,444 →
Substituted Dihydroxy-Bis-(5-Hydroxy-2 (5H)-Furanone-4-Yl)-Alkanes as Anti-Inflammatory Agents
Patent: 5,225,571 →
Application: 07/693,201 →
2- and 5- Alkyl and Phenyl Substituted 4-(1-Hydroxy, 1-Acyloxy or 1-Carbamoyloxy)-5-Hydroxy-2 (5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,183,906 →
Application: 07/693,204 →
Aqueous Ophthalmic Formulations and Methods for Preserving Same
Patent: 5,424,078 →
Application: 07/694,640 →
Anti-Inflammatory Furanones
Patent: 5,134,128 →
Application: 07/699,819 →
Ocular Hypotensive 2-Decarboxyl-2-Acylthioalkyl Prostaglandin Derivatives
Patent: 5,312,832 →
Application: 07/702,220 →
Anti-Inflammatory Furanone Compounds
Patent: 5,112,853 →
Application: 07/709,550 →
Combinations of Selective Alpha-Adrenergic Agonists and Antagonists Useful in Lowering Intraocular Pressure
Patent: 5,180,721 →
Application: 07/709,915 →
Process and Intermediates for Preparing Compounds Having a Disubsti- Tuted Acetylene Moiety and Retinoic Acid-Like Biological Activity
Patent: 5,248,777 →
Application: 07/731,161 →
Process and Intermediates for Preparing Compounds Having a Disubstituted Acetylene Moiety and Retinoic Acid-Like Biological Activity
Patent: 5,717,094 →
Application: 07/731,162 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2-Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydro- Quinolinyl Group Having Retinoid-Like Activity
Patent: 5,183,827 →
Application: 07/732,270 →
Leukotriene Receptor Antagonist and Antihistamine Complex Pharmaceutical Compositions
Patent: 5,276,044 →
Application: 07/745,232 →
Acetylenes Disubstituted with a Phenyl Group and a 2- Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,162,546 →
Application: 07/749,747 →
Process of Using Anti-Inflammatory Furanones as Selective Calcium Channel Inhibitors
Patent: 5,376,676 →
Application: 07/752,402 →
Di-[5-Hydroxy-2(5H)-2-Oxo-4-Furyl]Methyl-Alpha,Omega Alkane-Dioates and N,N-Bis-[5-Hydroxy-2(5H)-2-Oxo-4-Furyl]Methyl-Alpha,Omega- Dialkanoic Acid Amides as Anti-Inflammatory Agents
Patent: 5,171,864 →
Application: 07/752,404 →
Di-(5-Hydroxy-2(5H)2-Oxo-4-Furyl)Alkylmethyl-Alpha,Omega Alkane- Dioates and N,N-Bis-(5-Hydroxy-2(5H)2-Oxo-4-Furyl)Alkylmethyl-Alpha, Omega-Dialkanoic Acid Amides as Anti-Inflammatory Agents
Patent: 5,169,963 →
Application: 07/752,405 →
Methods for Using (2-Imidazolin-2-Ylamino) Tetrahydroquinoxalines
Patent: 5,204,347 →
Application: 07/758,696 →
Diagnostic Method for Determining Precorneal Retention Time of Ophthalmic Formulations
Patent: 5,323,775 →
Application: 07/759,530 →
Novel Pharmaceutical Epinephrine-Pilocarpine Compounds and Process of Preparation Thereof
Patent: 5,198,545 →
Application: 07/773,059 →
Self Sealing Product Delivery System
Patent: 5,197,638 →
Application: 07/785,588 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,234,926 →
Application: 07/792,832 →
Intermediates for Preparing 4-Substituted 2-5(H)-Furanones as Anti- Inflammatory Agents
Patent: 5,171,863 →
Application: 07/792,833 →
4-(1-Hydroxy-2-Substituted Amino)Ethyl-5-Hydroxy-2(5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,212,172 →
Application: 07/792,977 →
Nonirritating Nonionic Surfactant Compositions
Patent: 5,252,246 →
Application: 07/819,397 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,231,096 →
Application: 07/820,329 →
Polar C-1 Esters of Prostaglandins
Patent: 5,288,754 →
Application: 07/831,023 →
Substituted Phenylethenyl Compounds Having Retinoid-Like Biological Activity
Patent: 5,326,898 →
Application: 07/833,688 →
(2-Imidazolin-2-Ylamino) Quinoxaline Derivatives and Methods for Using Same
Patent: 5,198,442 →
Application: 07/836,061 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,264,578 →
Application: 07/836,635 →
Homo-Prostaglandin Derivatives as Ocular Hypotensives
Patent: 5,262,437 →
Application: 07/852,877 →
Reversible Gelation Emulsion Compositions and Methods of Use
Patent: 5,441,732 →
Application: 07/853,135 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Muscarinic Antagonists
Patent: 5,716,952 →
Application: 07/853,374 →
Method for Producing Amino-2-Imidazoline Derivatives
Patent: 5,237,072 →
Application: 07/855,211 →
Pharmaceutical Compositions and Method for Administering 3 and 4-Substituted 2(5H)-Furanones to a Mammal for Inhibiting Bone Loss
Patent: 5,268,387 →
Application: 07/872,308 →
Anti-Inflammatory Furanone Compounds
Patent: 5,258,400 →
Application: 07/872,776 →
Variable Block Lengths on-the-Fly Error Correcting Decoder
Patent: 5,329,535 →
Application: 07/876,593 →
Method for Determining Amount of Medication in an Implantable Device
Patent: 5,178,635 →
Application: 07/878,034 →
Tetralin Esters of Phenols or Benzoic Acids Having Retinoid Like Activity
Patent: 5,231,113 →
Application: 07/894,122 →
Method of Treatment with Compounds Having Retinoid-Like Activity and Reduced Skin Toxicity and Lacking Teratogenic Effects
Patent: 5,324,840 →
Application: 07/898,764 →
Ophthalmic Compositions and Methods for Preserving and Using Same
Patent: 5,277,901 →
Application: 07/912,862 →
7-Chromanyl Esters of Phenols and Benzoic Acids Having Retinoid-Like Activity
Patent: 5,324,744 →
Application: 07/918,538 →
Method for Reducing or Maintaining Intraocular Pressure in the Mammalian Eye by Administering Pharmaceutical Compositions Containing 2-(2-Alkylphenylamino)-Oxazolines, 2-(2-Alkylphenyl-Amino)-Thiazolines and 2-(2-Alkylphenylamino)-Imidazo
Patent: 5,252,595 →
Application: 07/926,252 →
Subconjunctival Implants for Ocular Drug Delivery
Patent: 5,300,114 →
Application: 07/926,402 →
Chemical Treatment to Improve Oxygen Permeability Through and Protein Deposition on Hydrophilic (Soft) and Rigid Gas Permeable (Rgp) Contact Lenses
Patent: 5,310,571 →
Application: 07/938,937 →
Use of 2-Substituted-Thiazolidine-4-Carboxylic Acids for Treatment of Cataract
Patent: 5,399,573 →
Application: 07/938,967 →
5-Substituted 3-Thiophene Sulfonamides as Antiglaucoma Agents
Patent: 5,300,499 →
Application: 07/939,189 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Tetralin Group and Having Retinoid Like Activity
Patent: 5,246,962 →
Application: 07/947,681 →
Non-Acidic Cyclopentane Heptanoic Acid, 2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Patent: 5,352,708 →
Application: 07/948,056 →
Method of Lowering Intraocular Pressure by Administering a Pharmaceutical Composition Containing 7-(5-Substituted Cyclopentyl) and 7-(5-Substituted-Cyclopentenyl) 5-Heptenoic Acids and Derivatives
Patent: 5,468,778 →
Application: 07/950,855 →
Azido Derivatives of Cyclopentane Heptanoic or Heptenoic Acid
Patent: 5,332,730 →
Application: 07/962,179 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administration of These Novel Compounds
Patent: 5,385,945 →
Application: 07/964,223 →
Process of Synthesizing Acetylenes Disubstituted with a Phenyl Group and a 2-Substituted Chromanyl, Thiocharomanyl or 1,2,3,4-Tetrahydro- Quinolinyl Group
Patent: 5,278,318 →
Application: 07/964,227 →
Cyclopentane Heptenylnitro and Heptanylnitro-2-Aliphatic or Aryl Aliphatic Derivatives and Homologues
Patent: 5,328,933 →
Application: 07/967,603 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2-Substituted 1,2,3,4-Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,272,156 →
Application: 07/967,630 →
Combinations of Selective Alpha-Adrenergic Agonists and Antagonists Useful in Lowering Intraocular Pressure
Patent: 5,281,591 →
Application: 07/967,888 →
Acetylenes Disubstituted with a Furyl Group and a Substituted Phenyl Group Having Retinoid Like Activity
Patent: 5,264,456 →
Application: 07/967,889 →
Intermediates and Processes for Preparing 4-Substituted 2-5(H)-Furanones as Anti-Inflammatory Agents
Patent: 5,298,633 →
Application: 07/967,895 →
Cyclopentane Heptenylsulfinylalkyl and Heptanylsulfinylalkyl-2-Aliphatic or Aryl Aliphatic Derivatives
Patent: 5,312,842 →
Application: 07/968,700 →
Method of Treating Ocular Hypertension with 8-Epi Prostaglandins
Patent: 6,124,353 →
Application: 07/975,194 →
(2-Imidazolin-2-Ylamino) Tetrahydroquinoxalines and Methods for Using Same
Patent: 5,300,504 →
Application: 07/995,218 →
Chromans and Thiochromans with Phenylethynyl Substituents at the 7- Position Having Retinold-Like Biological Activity
Patent: 5,346,915 →
Application: 08/001,009 →
Chromans and Thiochromans with Heteroarylethynyl Substituents at the 7-Position Having Retinoid-Like Biological Activity
Patent: 5,346,895 →
Application: 08/001,010 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,326,763 →
Application: 08/010,954 →
Method of Treatment with Compounds Having Selective Agonist-Like Activity on Rxr Retinoid Receptors
Patent: 5,455,265 →
Application: 08/016,404 →
Methods and Compositions for Inhibiting Deposit Formation on Contact Lenses
Patent: 6,136,850 →
Application: 08/016,931 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,348,972 →
Application: 08/027,624 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,380,877 →
Application: 08/027,627 →
Treatment of Mammals Afflicted with Tumors with Compounds Having Rxr Retinoid Receptor Agonist Activity
Patent: 5,399,586 →
Application: 08/029,801 →
Alkyl, Alkoxy and Thioalkoxy Substituted Diphenyl Acetylenes Having Retinoid Like Activity
Patent: 5,349,105 →
Application: 08/032,945 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,369,127 →
Application: 08/051,104 →
Ophthalmic Compositions and Methods for Preserving and Using Same
Patent: 5,387,394 →
Application: 08/059,522 →
Tetrahydronaphthyl and Cyclopropyl Substituted 1,3- Butadienes Having Retinoid-Like Activity
Patent: 5,344,959 →
Application: 08/063,540 →
5-Trans-Alcohols and Their Use as Ocular Hypotensives
Patent: 5,656,635 →
Application: 08/074,104 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Tetralin Group and Having Retinoid Like Activity
Patent: 5,354,776 →
Application: 08/084,843 →
Cyclopentane(Ene) Heptanoic or Cyclopentane(Ene) Heptenoic Acid, 2- Hydrocarbyl Sulfonamidomethyl and Derivatives Thereof as Therapeutic Agents
Patent: 5,387,608 →
Application: 08/108,209 →
Heteroaryl Substituted Phenylethenyl Compounds Having Retinoid-Like Biological Activity
Patent: 5,391,753 →
Application: 08/126,627 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,468,879 →
Application: 08/126,933 →
Pharmaceutical Compositions and Method for Administering 3 and 4- Substituted 2(5H)-Furanones to a Mammal for Inhibiting Bone Loss
Patent: 5,387,606 →
Application: 08/126,934 →
Heteroaryl Substituted Phenylethenyl Compounds Having Retinoid-Like Biological Activity
Patent: 5,434,173 →
Application: 08/126,951 →
Acetylenes Disubstituted with a Thiazole Group and a Substituted Phenyl Group Having Retinoid Like Activity
Patent: 5,414,007 →
Application: 08/126,952 →
1,11-Diesters of Prostaglandin-F2 Alpha Having a Polar Ester Group at C-1
Patent: 5,476,872 →
Application: 08/138,274 →
Method for Using 2-(2-Alkylphenylamino)-Oxzaolines as Adreneergic Agents
Patent: 5,580,892 →
Application: 08/141,143 →
7-Chromanyl Esters of Phenols and Benzoic Acids Having Retinoid-Like Activity
Patent: 5,348,975 →
Application: 08/143,682 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2- Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydro-Quinolinyl Group Having Retinoid-Like Activity
Patent: 5,407,937 →
Application: 08/144,178 →
Disubstituted Acetylenes Bearing Dizinyl Groups Having Retinoid Like Activity
Patent: 5,354,752 →
Application: 08/145,438 →
Nucleic Acis Encoding Human EP3 Prostaglandin Receptor
Patent: 6,057,433 →
Application: 08/155,005 →
Ophthalmic and Disinfecting Compositions and Methods for Preserving and Using Same
Patent: 5,451,398 →
Application: 08/174,485 →
7-[Carboxyalkyl or Alkenyl]-6-[Alkyl or Alkenyl] 3-Oxo-2,4-Dioxobicyclo-[3.2.1] Octane and Derivatives Thereof
Patent: 5,416,106 →
Application: 08/174,534 →
Cyclopentane(Ene) Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,545,665 →
Application: 08/174,535 →
Cyclohexene and Bicyclic Aromatic Substituted Ethyne Compounds Having Retinoid-Like Biological Activity
Patent: 5,470,999 →
Application: 08/175,706 →
Method for Determining Precorneal Retention Time of Opthalmic Formulations
Patent: 5,634,458 →
Application: 08/176,768 →
[4-(1,2-Epoxycyclohexanyl)But-3-En-1-Ynyl]Aromatic and Heteroaromatic Acids and Derivatives Having Retinoid-Like Biological Activity
Patent: 5,426,118 →
Application: 08/177,620 →
1,2-Epoxycyclohexanyl and Bicyclic Aromatic Substituted Ethyne Compounds Having Retinoid-Like Biological Activity
Patent: 5,451,605 →
Application: 08/177,621 →
Acetylenes Disubstituted with a Phenyl or Heteroaryl Group and a 2-Oxochromanyl, 2-Oxothiochromanyl or 2-Oxo-1,2,3,4-Tetrahydro- Quinolinyl Group Having Retinoid-Like Biological Activity
Patent: 5,399,561 →
Application: 08/178,714 →
Nonaqueous Fluorinated Drug Delivery Suspensions
Patent: 6,458,376 →
Application: 08/179,508 →
Process for Preparing 4,4-DIA1KY1-6-Halo-Chromans or Thiochromans Useful as Pharmaceutical Intermediates
Patent: 5,420,295 →
Application: 08/183,543 →
EP2-Receptor Agonists as Agents for Lowering Intraocular Pressure
Patent: 5,462,968 →
Application: 08/183,682 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,373,010 →
Application: 08/195,184 →
Compositions and Methods to Disinfect Contact Lenses
Patent: 6,338,847 →
Application: 08/203,837 →
Method and Compositions for the Treatment of Cerebral Palsy
Patent: 6,395,277 →
Application: 08/211,352 →
3 and 5 Alkyl and Phenyl 4-(Hydroxy or Acyloxy)-Alkyl Substituted 2(5H)-Furanones as Anti-Inflammatory Agents
Patent: 5,451,686 →
Application: 08/228,241 →
Nonirritating Nonionic Tissue Cleaning Compositions
Patent: 5,518,718 →
Application: 08/234,318 →
Substituted Thiazole Sulfonamides as Antiglaucoma Agents
Patent: 5,519,040 →
Application: 08/236,720 →
Nonirritating Emulsions for Sensitive Tissue
Patent: 5,474,979 →
Application: 08/243,279 →
Tetrahydronaphthyl and Thiazole, Oxazole or Imidazole Substituted Ethene Derivatives Having Retinoid-Like Activity, Reduced Skin Toxicity and Reduced Teratogenecity
Patent: 5,475,113 →
Application: 08/260,181 →
Nonaqueous Fluorinated Drug Delivery Vehicle Suspensions
Patent: 5,518,731 →
Application: 08/260,482 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Calcium Chelators
Patent: 5,891,911 →
Application: 08/260,648 →
N-Substituted Derivatives of 3R, 4R-Ethyl-[(1-Methyl-1H-Imidazol-5-Yl)Methyl]-2-Pyrrolidinone
Patent: 5,453,434 →
Application: 08/265,163 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Tetralin Group and Having Retinoid Like Activity
Patent: 5,466,690 →
Application: 08/276,385 →
In-The-Eye Use of Chlorine Dioxide-Containing Compositions
Patent: 5,736,165 →
Application: 08/277,718 →
Cyclopentane(Ene) Heptanoic or Cyclopentane(Ene) Heptenoic Acid, 2-Hydrocarbyl Sulfonamidomethyl and Derivatives Thereof as Therapeutic Agents
Patent: 5,457,131 →
Application: 08/292,543 →
Use of 5-Ht Ligands as Anti-Pruritic Agents
Patent: 5,521,183 →
Application: 08/298,245 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,418,234 →
Application: 08/298,494 →
Combination of Levobunolol and Dipivefrin for Topical Ophthalmic Use
Patent: 5,733,938 →
Application: 08/303,850 →
Use of 2-Substituted-Thiazolidine-4-Carboxylic Acids for Treatment of Cataract
Patent: 5,589,464 →
Application: 08/316,596 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,602,130 →
Application: 08/323,174 →
Method for Preparing Esters of Halonicotinic Acids
Patent: 5,659,042 →
Application: 08/329,023 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,552,403 →
Application: 08/332,029 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,523,296 →
Application: 08/345,176 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Chloride Channel Blockers
Patent: 5,559,151 →
Application: 08/346,660 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Guanylate Cyclase Inhibitors
Patent: 5,602,143 →
Application: 08/352,018 →
Compositions and Methods for Disinfecting Contact Lenses and Reducing Proteinacedus Deposit Formation
Patent: 5,648,074 →
Application: 08/353,782 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administration of These Novel Compounds
Patent: 5,552,434 →
Application: 08/355,463 →
Acetylenes Disubstituted with a 5 Oxo Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,618,943 →
Application: 08/366,167 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,514,825 →
Application: 08/366,168 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl of Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,599,967 →
Application: 08/366,169 →
Acetylenes Disubstituted with Hydroxyaryl and Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,498,795 →
Application: 08/366,170 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,543,534 →
Application: 08/366,172 →
Acetylenes Disubstituted with 2-Tetrahydropyranoxyaryl and Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,534,641 →
Application: 08/366,173 →
Oxiranyls Disubstituted with a Phenyl Group and a Substituted Chromanyl or Tetrahydroquinolinyl Group Having Retinoid Like Activity
Patent: 5,556,996 →
Application: 08/366,174 →
Acetylenes Disubstituted with a 5-Amino or Substituted 5-Amino Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,489,584 →
Application: 08/366,182 →
Acetylenes Disubstituted with a 5 Substituted Dihydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,618,931 →
Application: 08/366,183 →
Substituted Acetylenes Having Retinoid-Like Biological Activity
Patent: 5,648,514 →
Application: 08/366,193 →
Non-Acidic Cyclopentane Heptanoic Acid, 2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Patent: 5,607,978 →
Application: 08/371,339 →
Methods and Means for Control of Proliferation of Remnant Cells Following Surgery
Patent: 5,627,162 →
Application: 08/374,360 →
7-[Carboxyalkyl or Alkenyl]-6-[Alkyl or Alkenyl] 3-Oxo-2,4- Dioxobicyclo-[3.2.1] Octane and Derivatives Thereof
Patent: 5,516,791 →
Application: 08/378,414 →
Gene Sequence Induced in Skin by Retinoids
Patent: 5,650,279 →
Application: 08/379,280 →
Pharmaceutical Compositions and Method for Administering 3 and 4-Substituted 2(5H)-Furanones to a Mammal for Inhibiting Bone Lose
Patent: 5,541,221 →
Application: 08/380,482 →
Method of Preventing Proliferation of Retinal Pigment Epithelium by Retinoic Acid Receptor Agonists
Patent: 5,824,685 →
Application: 08/383,741 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Substitued Phenyl Group Having Retinoid Like Activity
Patent: 5,516,904 →
Application: 08/384,886 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2-Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,534,516 →
Application: 08/385,000 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,561,132 →
Application: 08/390,265 →
Process for Preparing 4,4-Dialkyl-6-Halo-Chromans or Thiochromans Useful as Pharmaceutical Intermediates
Patent: 5,519,150 →
Application: 08/396,848 →
Multiple Fluid Dispensing Device for Low Surface Tension Formulations
Patent: 5,564,596 →
Application: 08/405,143 →
[4-(1,2-Epoxycyclohexanyl)But-3-En-1-Ynyl]Aromatic and Heteroaromatic Acids and Derivatives Having Retinoid-Like Biological Activity
Patent: 5,618,836 →
Application: 08/419,626 →
Botulinum Toxin Antibody Detection Assay
Patent: 5,731,161 →
Application: 08/426,796 →
Method for Inhibiting Gene Expression Promoted by AP1 Protein with Rarbeta Selective Retinoids and Method for Treatment of Diseases and Conditons with Such Retinoids
Patent: 6,025,388 →
Application: 08/428,957 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Potassium Channel Blockers
Patent: 5,573,758 →
Application: 08/431,170 →
Polymer, Article and Method for Inhibiting the Growth of Ocular Pathogens in Eye Care Products
Patent: 5,739,178 →
Application: 08/440,579 →
Acetylenes Disubstituted with a Phenyl or Heteroaryl Gruop and a 2-Thio-1,2,3,4-Tetrahdroquinolinyl, 2-Alkylthio-3,4-Dihydroquinolinyl or 2-Alkoxy-3,4-Dihydroquinolinyl Group Having Retinoid-Like Biological Activity
Patent: 5,616,712 →
Application: 08/442,223 →
Cyclopentane(Ene)Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,587,391 →
Application: 08/445,842 →
Acetylenes Disubstituted with a Thienyl or Furyl Group and a 2-Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,599,819 →
Application: 08/458,389 →
Phenyl or Heteroaryl and Tetrahydronaphthyl Substituted Diene Compounds Having Retinoid Like Biological Activity
Patent: 5,602,135 →
Application: 08/458,394 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,587,376 →
Application: 08/458,949 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2- Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydro- Quinolinyl Group Having Retinoid-Like Activity
Patent: 5,616,597 →
Application: 08/460,477 →
Phenyl or Heteroaryl and Tetrahydronaphthyl Substituted Diene Compound Having Retinoid Like Biological Activity
Patent: 5,696,162 →
Application: 08/460,487 →
2,4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 5,675,033 →
Application: 08/466,000 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,677,451 →
Application: 08/466,003 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,663,347 →
Application: 08/466,005 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,654,329 →
Application: 08/485,521 →
Method for Identifying Muscarinic Agents Lacking Miotic Side Effects
Patent: 5,677,327 →
Application: 08/493,509 →
Method for Fabricating Semiconductor Memory Element
Patent: 5,654,223 →
Application: 08/495,270 →
Method of Using (2-Imidazolin-2-Ylamino) Quinoxalines in Treating Ocular Neural Injury
Patent: 5,856,329 →
Application: 08/496,262 →
Magnetic Field Sense System for the Protection of Connected Electronic Devices
Patent: 5,629,622 →
Application: 08/501,264 →
Instrument and Method of Measuring Torticollis
Patent: 5,845,638 →
Application: 08/510,526 →
EP2-Recptor Agonists as Agents for Lowering Intraocular Pressure
Patent: 5,698,598 →
Application: 08/511,182 →
Method for Effecting Vasodilation with (1,5-Inter)Aryl Prostaglandin Derivatives
Patent: 5,661,178 →
Application: 08/522,775 →
Intraocular Pressure Reducing 15-Acyl Prostaglandins
Patent: 5,574,066 →
Application: 08/531,488 →
Conformationally Rigid Bicycle and Adamantane Derivatives Useful as ALPHA2-Adrenergic Blocking Agents
Patent: 5,731,337 →
Application: 08/538,694 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,723,620 →
Application: 08/552,813 →
Sulfides, Sulfoxides and Sulfones Disubstituted with a Tetrahydronaphthalenyl, Chromanyl, Thiochromanyl or Tetrahydroquinolinyl and Substituted Phenyl or Heteroaryl Group, Having Retinoid-Like Biological Activity
Patent: 5,672,710 →
Application: 08/552,965 →
Method for Delivering Nonaqueous Fluorinated Drug Delivery Vehicle Suspensions
Patent: 5,620,699 →
Application: 08/556,277 →
Substituted Heteroarylamides Having Retinoid-Like Biological Activity
Patent: 5,663,357 →
Application: 08/561,999 →
Aryl or Heteroaryl Amides of Tetrahydronaphthalene, Chroman, Thiochroman and 1,2,3,4,-Tetrahydroquinoline Carboxylic Acids, Having an Electron Withdrawing Substituent in the Aromatic or Heteroaromatic Moiety, Having Retinoid-Like Biological Activity
Patent: 5,675,024 →
Application: 08/562,000 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administra- Tion of These Novel Compounds
Patent: 5,674,910 →
Application: 08/572,437 →
Enhancement of Benzalkonium Chloride Preservative Activity in Formulations Containing an Incompatible Drug Using Amino Acids Having Net Positive Charge
Patent: 5,658,948 →
Application: 08/579,001 →
Methods of Treatment with Compounds Having Rar Alpha Receptor Specific or Selective Activity
Patent: 5,965,606 →
Application: 08/580,553 →
..3"-Thioxacyclohex-1"-Enyl)-But-3'-Ene-1'-Ynyl]Aryl and [(3"- Thioxacyclohex-1"-Enyl)]-but-3'-Ene-1'-Ynyl]Heteroaryl Carboxylic Acids and Esters Having Retinoid-Like Biological Activity
Patent: 5,688,957 →
Application: 08/581,121 →
Non-Acidic Cyclopentane Heptanoic Acid, 2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Patent: 5,688,819 →
Application: 08/605,567 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,714,621 →
Application: 08/607,736 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,591,858 →
Application: 08/607,737 →
Cyclopentane Heptan(Ene)Oic Acid, 2- Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 5,741,810 →
Application: 08/608,794 →
Method of Identifying Negative Hormone and/or Antagonist Activities
Patent: 5,776,699 →
Application: 08/613,863 →
Injectable Therapy for Control of Muscle Spasms and Pain Related to Muscle Spasms
Patent: 5,721,215 →
Application: 08/619,780 →
Cyclopentane(Ene) Heptanoic or Cyclopentane(Ene) Heptenoic Acid, 2- Hydrocarbyl Phosphinyloxyalkyl or Phosphonamidoalkyl as Therapeutic Agents
Patent: 5,658,897 →
Application: 08/629,283 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,756,503 →
Application: 08/636,740 →
Thromboxane Ligands Without Blood Clotting Side Effects
Patent: 5,650,431 →
Application: 08/645,467 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,710,288 →
Application: 08/646,697 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,654,469 →
Application: 08/656,127 →
Acetylenes Disubstituted with 2-Tetrahydropyranoxyaryl and Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,698,700 →
Application: 08/656,128 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,648,503 →
Application: 08/656,134 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,605,915 →
Application: 08/656,135 →
2,4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 5,663,367 →
Application: 08/656,137 →
Oxime Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,723,666 →
Application: 08/667,215 →
O- or S- Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,808,124 →
Application: 08/667,216 →
Alkyl or Aryl Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,773,594 →
Application: 08/667,663 →
O- or S- Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,741,896 →
Application: 08/667,664 →
Oxo-Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,747,542 →
Application: 08/667,666 →
Diagnostic Formulation Apparatus for Determing Precorneal Retention Time of Ophthalmic Formulations
Patent: 5,707,614 →
Application: 08/673,197 →
Process for Making Pilolactam and Derivatives Thereof
Patent: 5,675,019 →
Application: 08/685,897 →
Improved Lithium and Amine Disssolving Metal Reducition
Patent: 5,675,038 →
Application: 08/685,902 →
Compositions and Methods for Disinfecting Contact Lenses and Preserving Contact Lens Care Products
Patent: 6,024,954 →
Application: 08/692,867 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,703,077 →
Application: 08/693,745 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,714,486 →
Application: 08/695,103 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Chlodride Channel Blockers
Patent: 5,705,530 →
Application: 08/716,756 →
Cyclopentane Heptan(Ene)Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 5,834,498 →
Application: 08/726,921 →
Acetylenes Distubstituted with a Heteroaromatic Group and a 2-Substituted Chromanyl, Thiochromanyl or 1, 2, 3, 4, - Tetrahydro-Quinolinyl Group Having Retinoid-Like Activity
Patent: 5,677,323 →
Application: 08/739,000 →
Method for Using Pharmaceutical Compositions Containing 2-(2-Alkylphenyl-Amino)-Thiazolines as Adrenergic Agents
Patent: 5,708,015 →
Application: 08/739,232 →
Point of Fill Air System
Patent: 5,759,218 →
Application: 08/740,099 →
Cyclopentane(Ene) Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,681,848 →
Application: 08/740,883 →
N-Aryl Substituted Tetrahydroquinolines Having Retinoid Agonist, Retinoid Antagonist or Retinoid Inverse Agonist Type Biological Activity
Patent: 5,739,338 →
Application: 08/744,210 →
Benzo[1,2-G]-Chrom-3-Ene and Benzo[1,2-G]-Thiochrom-3-Ene Derivatives
Patent: 5,728,846 →
Application: 08/764,466 →
Phenyl or Heteroaryl and Tetrahydronaphthyl Substituted Diene Compounds Having Retinoid Like Biological Activity
Patent: 5,677,320 →
Application: 08/781,153 →
Barrier Packaging and Materials Therefor
Patent: 5,799,837 →
Application: 08/785,957 →
Method for Preventing Onset of Restenosis After Angioplasty Employing a Retinoid
Patent: 5,798,372 →
Application: 08/794,289 →
Method for Effecting Vasodilation with (1,5-Inter) Aryl Prostaglandin Derivatives
Patent: 5,750,784 →
Application: 08/801,445 →
2,4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 5,780,647 →
Application: 08/805,793 →
Retinoid Induced Gene
Patent: 5,776,687 →
Application: 08/808,303 →
Aryl-And Heteroarylcyclohexenyl Substituted Alkenes Having Retinoid Agonist, Antagonist or Inverse Agonist Type Biological Activity
Patent: 5,760,276 →
Application: 08/810,826 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,750,693 →
Application: 08/820,791 →
Substituted Aryl or Heteroarylamides Having Retinoid-Like Biological Activity
Patent: 5,917,048 →
Application: 08/820,792 →
5-Trans-Prostaglandins of the F Series and Their Use as Ocular Hypotensives
Patent: 5,767,154 →
Application: 08/822,525 →
Thromboxane Ligands Without Blood Clotting Side Effects
Patent: 5,741,812 →
Application: 08/832,431 →
Process for Transmitting Data Coded with Adjustable Error Correction Codes
Patent: 5,923,274 →
Application: 08/839,245 →
Substituted Diaryl or Diheteroaryl Methanes, Ethers and Amines Having Retinoid Agonist, Antagonist or Inverse Agonist Type Biological Activity
Patent: 5,919,970 →
Application: 08/840,040 →
Trisubstituted Phenyl Derivatives Having Retinoid Agonist, Antagonist or Inverse Agonist Type Biological Activity
Patent: 6,037,488 →
Application: 08/845,019 →
Acetylenes Disubstituted with a 5 Alkyl, Aryl or Heteroaryl Substituted Dihydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,808,083 →
Application: 08/854,297 →
Cyclopentane(Ene) Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,798,378 →
Application: 08/861,414 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonistic Activities
Patent: 5,952,345 →
Application: 08/871,093 →
Method of Preventing Proliferation of Retinal Pigment Epithelium by Retinoic Acid Receptor Agonists
Patent: 6,075,032 →
Application: 08/875,665 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,773,440 →
Application: 08/880,473 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 5,877,207 →
Application: 08/880,823 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Potassium Channel Blockers
Patent: 5,925,342 →
Application: 08/891,623 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administration of These Novel Compounds
Patent: 5,773,654 →
Application: 08/899,972 →
2, 4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 5,917,082 →
Application: 08/918,735 →
Acetylenes Disubstituted with 2-Terahydropyranoxy-Aryl and Aryl of Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,847,160 →
Application: 08/923,720 →
Aryl or Heteroaryl Amides of Tetrahydronaphthalene, Chroman, Thiochroman and 1,2,3,4-Tetrahydroquinoline Carboxylic Acids, Having an Electron Withdrawing Substituent in the Aromatic or Heteroaromatic Moiety, Having Retinoid-Like Biological Activity
Patent: 5,856,490 →
Application: 08/923,864 →
O-Or S-Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 6,051,731 →
Application: 08/923,897 →
Thromboxane Ligands
Patent: 6,017,953 →
Application: 08/926,662 →
Aryl-Imidazolines and Aryl-Imidazoles Useful as Alpha-2 Adrenergic Agonists Without Cardiovascular Side Effects
Patent: 6,087,361 →
Application: 08/971,952 →
Cyclopentane Heptan(Ene)Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 6,124,344 →
Application: 08/974,067 →
Ep 2 Receptor Agonists as Neuroprotective Agents for the Eye
Patent: 5,877,211 →
Application: 08/975,314 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,808,101 →
Application: 08/975,811 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,814,657 →
Application: 08/975,812 →
Cyclopentane Heptan (Ene)Oic Acid,2- Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 6,096,902 →
Application: 08/994,810 →
Retinoid Induced Gene
Patent: 6,294,657 →
Application: 08/996,533 →
Synthesis and Useof Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 5,958,954 →
Application: 08/998,319 →
Method for Providing a Neuroprotective Effect to the Mammalian Eye by Administration of Chloride Channel Blockers
Patent: 5,866,605 →
Application: 08/998,912 →
Conformationally Rigid Bicyclic and Adamantane Derivatives Useful as A2-Adrenergic Blocking Agents
Patent: 6,150,389 →
Application: 09/003,902 →
Method for Preventing Onset of Restenosis After Angioplasty Employing an Rxr-Specific Retinoid and a Ppary Ligand
Patent: 6,034,110 →
Application: 09/005,790 →
Emulsion Eye Drop for Alleviation of Dry Eye Related Symptoms in Dry Eye Patients and/or Contact Lens Wearers
Patent: 5,981,607 →
Application: 09/008,924 →
Polymer,Article and Method for Inhibiting the Growth of Ocular Pathogens in Eye Care Products
Patent: 5,854,303 →
Application: 09/013,725 →
Benzo[1,2-G]-Chrom-3-Ene, and Benzo[1,2-G]-Thiochrom-3-Ene Derivatives
Patent: 6,087,505 →
Application: 09/030,350 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 6,090,826 →
Application: 09/030,351 →
Alkylidene Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 5,998,655 →
Application: 09/030,353 →
Methods of Identifying Compounds Havign Nuclear Receptor Negative Hormone and/or Antagonist Activities
Patent: 6,218,128 →
Application: 09/042,943 →
Alkyl or Aryl Substituted Dihydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 6,117,987 →
Application: 09/057,386 →
Methods and Compositions for Reducing or Maintaining Body Weight in a Mammal
Patent: 5,965,621 →
Application: 09/070,335 →
Cyclopentane(Ene) Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,906,989 →
Application: 09/084,805 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,874,460 →
Application: 09/094,269 →
Cholinergic Agents in the Treatment of Presbyopia
Patent: 6,291,466 →
Application: 09/126,064 →
Acetylenes Disubstituted with a 5 Alkyl, Aryl or Heteroaryl Substituted Dihydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,998,471 →
Application: 09/132,435 →
Sterile Bioerodible Occular Implant Device with a Retinoid for Improved Biocompatability
Patent: 6,074,661 →
Application: 09/150,990 →
Method and Apparatus for Detecting a Data Signal on a Carrier Medium
Patent: 6,292,517 →
Application: 09/153,305 →
2,4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 6,034,242 →
Application: 09/165,917 →
Aryl or Heteroaryl Amides of Tetrahydronaphthalene, Chroman, Thiochroman and 1,2,3,4-Tetrahydroquinoline Carboxylic Acids, Having an Electron Withdrawing Substituent in the Aromatic or Heteroaromatic Moiety, Having Retinoid-Like Biological Activity
Patent: 6,034,244 →
Application: 09/173,574 →
Method of Preventing Proliferation of Retinal Pigment Epithelium by Retinoic Acid Receptor Agonists
Patent: 6,071,924 →
Application: 09/175,192 →
Cyclopentane Heptan(Ene) Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 5,972,991 →
Application: 09/185,403 →
EP2-Receptor Agonists as Neuroprotective Agents for the Eye
Patent: 6,090,847 →
Application: 09/185,405 →
Cyclopentane(Ene)Oic Acid, 2-Alkenyl Derivatives as Therapeutic Agents
Patent: 6,258,844 →
Application: 09/194,457 →
Substituted Aryl or Heteroarylamides Having Retinoid-Like Biological Activity
Patent: 6,051,713 →
Application: 09/215,509 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 6,323,204 →
Application: 09/222,844 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 6,008,204 →
Application: 09/222,983 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 6,090,810 →
Application: 09/222,984 →
Cyclopentane(Ene) Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,990,138 →
Application: 09/225,034 →
Cyclopentane Heptan (Ene) Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 6,160,129 →
Application: 09/243,344 →
Substituted Diaryl or Diheteroaryl Methanes, Ethers and Amines Having Retinoid Agonist, Antagonist or Inverse Agonist Type Biological Activity
Patent: 6,187,950 →
Application: 09/267,992 →
Cyclopentane Heptan(Ene)Oic Acid, 2-Heteroarylalkenyl Derivatives as Therapeutic Agents
Patent: 6,037,364 →
Application: 09/295,003 →
Methods of Treatment with Compounds Having Rar Receptor Specific or Selective Activity
Patent: 6,534,544 →
Application: 09/350,310 →
Sterile Bioerodible Implant Device with a Retinoid for Improved Biocompatability
Patent: 6,110,485 →
Application: 09/356,074 →
Human EP3, Prostaglandin Receptor
Patent: 6,197,933 →
Application: 09/363,783 →
2,4-Pentadienoic Acid Derivatives Having Retinoid-Like Biological Activity
Patent: 6,114,533 →
Application: 09/390,825 →
Trisubstituted Phenyl Derivatives Having Retinoid Agonist or Inverse Agonist Type Biological
Patent: 6,225,494 →
Application: 09/398,564 →
Acetylenes Disubstituted with a 5 Alkyl, Aryl or Heteroaryl Substituted Dihydronaphtyl Group and with an Aryl or Reteroaryl Group Having Retinoit-Like with an Aryl or Heteroaryl Goup Having Retinoid-Like Biological Activity
Patent: 6,355,806 →
Application: 09/398,613 →
Thromboxane Ligands
Patent: 6,090,845 →
Application: 09/407,937 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 6,228,848 →
Application: 09/447,082 →
Cyclopentane Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 6,303,658 →
Application: 09/448,082 →
Method for Inhibiting Gene Expression Promoted by AP1 Protein with Rarbeta Selective Retinoids and Method for Treatment of Diseases and Conditions with Such Retinoids
Patent: 6,369,100 →
Application: 09/482,589 →
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
Patent: 6,235,923 →
Application: 09/490,658 →
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
Patent: 6,124,455 →
Application: 09/491,176 →
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological biological activity
Patent: 6,187,933 →
Application: 09/492,495 →
Non-Acidic Cyclopentane Heptanoic Acid,2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Patent: 6,403,649 →
Application: 09/519,834 →
Cyclopentane heptan(ENE)oic acid, 2-Heteroarylalkenyl derivatives as therapeutic agents
Patent: 6,204,287 →
Application: 09/523,880 →
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 6,521,624 →
Application: 09/535,042 →
Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
Patent: 6,372,753 →
Application: 09/536,221 →
Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents
Patent: 6,319,935 →
Application: 09/542,216 →
Substituted aryl or heteroarylamides having retinoid-like biological actitvity
Patent: 6,245,786 →
Application: 09/550,744 →
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
Patent: 6,344,463 →
Application: 09/611,889 →
2,4-Pentadienoic acid derivatives having retinoid-like biological acitivity
Patent: 6,313,163 →
Application: 09/640,850 →
Cyclopentane heptan(ene)oic acid, 2-heteroarylalk(en)yl derivatives as therapeutic agents
Patent: 6,248,773 →
Application: 09/643,330 →
Substituted Diaryl or Diheteroaryl Methanes,Ethers and Amines Having Retinoid Agonist,Antagonist or Inverse Agonist Type Biological Activity
Patent: 6,455,701 →
Application: 09/708,972 →
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Patent: 6,344,561 →
Application: 09/735,172 →
Publication: US 2001/0000511
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
Patent: 6,310,087 →
Application: 09/795,982 →
Publication: US 2001/0016597
Synthesis and Use of Retinoid Compounds Having Negative Hormone and/or Antagonist Activities
Patent: 6,469,028 →
Application: 09/821,673 →
Publication: US 2002/0156054
Substituted aryl or heteroarylamides having retinoid-like biological activity
Patent: 6,320,047 →
Application: 09/829,310 →
Thromboxane Ligands Without Blood Clotting Side Effects
Patent: 6,462,077 →
Application: 09/899,713 →
O- or S- Substituted Tetrahydronaphthalene Derivatives Having Retinoid and/or Retinoid Antagonist-Like Biological Activity
Patent: 6,465,663 →
Application: 09/900,593 →
Publication: US 2002/0099038
Cyclopentane(Ene)Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 6,414,022 →
Application: 09/919,318 →
Publication: US 2002/0002150
Substituted Aryl or Heteroarylamides Having Retinoid-Like Biological Activity
Patent: 6,437,129 →
Application: 09/982,362 →
Publication: US 2002/0091262
Horizontal Instrument for Measuring Torticollis
Patent: 430,296 →
Application: 29/040,336 →
Vertical Instrument for Measuring Torticollis
Patent: 379,657 →
Application: 29/043,929 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. May 20, 1983
From: MITCHELL, DAVID W.
To: ALLERGAN PHARMACEUTICALS, INC., A CORP. OF DE
Reel/Frame 004133/0911 →
Assignment of Assignors Interest. Jan 11, 1988
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC., A CORP. OF DE.
Reel/Frame 004823/0412 →
Assignment of Assignors Interest. Jan 27, 1989
From: LEE, GARY C. M.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005012/0303 →
Assignment of Assignors Interest. Jun 30, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005125/0286 →
Assignment of Assignors Interest. Aug 30, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005136/0882 →
Assignment of Assignors Interest. Aug 30, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005133/0852 →
Assignment of Assignors Interest. Sep 19, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005151/0224 →
Assignment of Assignors Interest. Sep 19, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005151/0046 →
Assignment of Assignors Interest. Sep 19, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005151/0251 →
Assignment of Assignors Interest. Sep 26, 1989
From: GLUCHOWSKI, CHARLES
To: ALLERGAN, INC., 2525 DUPONT DRIVE, IRVINE, CA 92715 A CORP. OF DE
Reel/Frame 005144/0269 →
Assignment of Assignors Interest. Oct 12, 1989
From: GLUCHOWSKI, CHARLES
To: ALLERGAN, INC., A CORP. OF DELAWARE
Reel/Frame 005158/0564 →
Assignment of Assignors Interest. Oct 25, 1989
From: LEE, GARY C. M.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005163/0959 →
Assignment of Assignors Interest. Oct 25, 1989
From: LEE, GARY C. M.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005163/0971 →
Assignment of Assignors Interest. Oct 25, 1989
From: LEE, GARY C. M.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005163/0888 →
Assignment of Assignors Interest. Oct 25, 1989
From: LEE, GARY C. M.
To: ALLERGAN, INC., A CORP. OF DE
Reel/Frame 005163/0889 →
Assignment of Assignors Interest. Oct 31, 1989
From: GLUCHOWSKI, CHARLES
To: ALLERGAN, INC.
Reel/Frame 005170/0339 →
Assignment of Assignors Interest. Nov 13, 1989
From: ALBAUGH, PAMELA
To: ALLERGAN, INC.
Reel/Frame 005177/0783 →
Assignment of Assignors Interest. Nov 27, 1989
From: ALLERGAN, INCORPORATED
To: BOSTON UNIVERSITY, 147 BAY STATE ROAD, BOSTON, MA 02215 A CORP. OF MA
Reel/Frame 005190/0413 →
Assignment of Assignors Interest. Dec 4, 1989
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC., 2525 DUPONT DRIVE, IRVINE, CA. 92715, A CORP. OF DE.
Reel/Frame 005186/0940 →
Assignment of Assignors Interest. Mar 30, 1990
From: KOZIOL, JEFFEREY E.; PEYMAN, GHOLAM A.
To: ALLERGAN, INCORPORATED, A CORP. OF DE
Reel/Frame 005262/0517 →
Assignment of Assignors Interest. Oct 9, 1990
From: CHANDRARATNA, ROSHANTHA A. S.
To: ALLERGAN, INC.
Reel/Frame 005467/0274 →
Assignment of Assignors Interest. Nov 16, 1990
From: TRUSTEES OF BOSTON UNIVERSITY, THE
To: ALLERGAN, INCORPORATED, 2525 DUPONT DRIVE, IRVINE, CA 92713, A CORP. OF DE
Reel/Frame 005515/0730 →
Assignment of Assignor's Interest May 6, 1996
From: ALLERGAN, INC.
To: ALLERGAN
Reel/Frame 008239/0239 →
Exclusive License May 9, 2001
From: ALLERGAN, INC.; ALLERGAN SALES, INC.; ALLERGAN AMERICA, INC.; ALLERGAN PHARMACEUTICALS (IRELAND), LTD.
To: BARDEEN SCIENCES COMPANY, LLC
Reel/Frame 011783/0633 →
Security Agreement Sep 6, 2002
From: ADVANCED MEDICAL OPTICS, INC.; AMO HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 013203/0039 →